SNX

TD SYNNEX Corporation

$248.21

-0.14% 2026-10-20

Information TechnologyS&P 400

1M 3M 6M 1Y 2Y

SNXSPY

-9.9%

-6.6%

-0.2%

+15.8%

YTD

+66.8%

+61.6%

Live chart

Loading live chart…

Grades vs sector

Momentum

68th pct in sector

12-1 return: +65.4%
Percentile within its GICS sector across the S&P 1500.

Growth

84th pct in sector

A-

Revenue growth (YoY): +37.7%
Percentile within its GICS sector across the S&P 1500.

Value

88th pct in sector

A-

Forward E/P: 10.0% · EBITDA/EV: 9.9%
Percentile within its GICS sector across the S&P 1500.

Profitability

34th pct in sector

C-

Profit margin: +1.8% · Return on equity: +14.9%
Percentile within its GICS sector across the S&P 1500.

Revisions

Not enough data yet

–

EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Our models

Not held by any of our 5 live models right now.

Quality Growth

not ranked (outside this model's universe or screens)

Momentum Top 15

not ranked (outside this model's universe or screens)

Momentum Blend

not in the current book

New Highs Growth

not ranked (outside this model's universe or screens)

Conviction 20

not in the current book

News

More news

AVT Surges 88.5% in a Year: Should You Buy, Sell or Hold the Stock?

Zacks · Oct 13

TD SYNNEX Surges 78% YTD: Is the SNX Stock Still Worth Buying?

Zacks · Oct 09

Key stats

Market cap$19.8B

P/E (trailing)15.1

P/E (forward)10.1

52-week range142.22 – 298.77

Revenue growth (YoY, latest qtr)+37.7%

Dividend yield0.77%

Analyst consensusBuy (11)

Mean price target$339.64 (+37%)

Valuation and fundamentals

Valuation & fundamentals

Bottom line

No cash-flow valuation

Model read-out from the numbers below, not advice. Score +3 (DCF counts double).

▲Forward P/E vs sector10.1x vs median 16.9x

▲Piotroski F-score7/9

•Altman Z2.6 (grey)

▲Net debt / EBITDA1.0x

▲Analyst target+37% (11 analysts)

Discounted cash flow

Trailing free cash flow is negative or missing, so a cash-flow DCF isn't meaningful by default. You can enter your own assumptions below.

Reverse DCFfor context, not a signal

Trailing free cash flow is zero or negative, so there's no growth rate to solve for. The price is betting on a turnaround to positive cash flow.

Edit assumptions · recalculates instantly

Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-08-31). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.37 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs Information Technology

P/E (trailing)

sector median 35.9× · 9th pct

15.1×
cheaper

Forward P/E

sector median 16.9× · 13th pct

10.1×
cheaper

EV / EBITDA

sector median 20.8× · 10th pct

9.0×
cheaper

Price / sales

sector median 4.6× · 1st pct

0.3×
cheaper

Price / book

sector median 5.1× · 16th pct

2.1×
cheaper

FCF yield

sector median 3.5% · 3rd pct

-3.6%
pricier

Forward EPS $24.63 vs trailing $16.40 (+50% expected growth). Forward P/E uses analysts' next-12-month estimate.

Quality & financial health

Gross margin

6.9%

Operating margin

2.7%

FCF margin

-0.9%

Net margin

1.8%

Return on equity

14.3%

Return on invested capital

13.4%

Net debt / EBITDA

1.0×

Current ratio

1.2×

Interest cover

6.4×

Cash conversion (OCF/NI)

-0.5×

Piotroski F-score 7/9 · last two fiscal years

✓ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✓ No share dilution✓ Gross margin improved✗ Asset turnover improved

Altman Z-score 2.6 (grey zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.

Analysts

Mean target

$340

+37%

Analysts

Buy

Range

$287–$379

low – high

● price · ◆ mean target

Annual history

FY	Revenue	Net income	Free cash flow
2025	$62.5B	$827.7M	$1.5B
2024	$58.5B	$689.1M	$1.2B
2023	$57.6B	$626.9M	$1.4B
2022	$62.3B	$651.3M	$-114.9M
2021	$31.6B	$395.1M	$770.1M
2020	$20.0B	$529.2M	$1.8B

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +0.1%.

Earnings

Next report: 2027-01-07 · before open · EPS est 5.99

EstimateActual (beat)Actual (miss)

Report	EPS est	Actual	Surprise
2026-09-24	4.70	5.68	+20.8%
2026-06-25	4.14	4.85	+17.1%
2026-03-31	3.31	4.73	+43.0%
2026-01-08	3.73	3.83	+2.7%
2025-09-25	3.05	3.58	+17.5%
2025-06-24	2.72	2.99	+10.1%
2025-03-27	2.91	2.80	-3.6%
2025-01-10	3.05	3.09	+1.4%

Quarterly revenue

Quarter	Revenue	YoY
2026-05-31	$19.6B	+31.0%
2026-02-28	$17.2B	–
2025-11-30	$17.4B	–
2025-08-31	$15.7B	–
2025-05-31	$14.9B	–

Analyst actions

UBS

2026-09-25 · main

Buy → Buy
PT $379

Morgan Stanley

2026-09-25 · main

Overweight → Overweight
PT $359

Morgan Stanley

2026-09-15 · main

Overweight → Overweight
PT $334

Barclays

2026-09-08 · main

Equal-Weight → Equal-Weight
PT $287

Barclays

2026-07-02 · main

Equal-Weight → Equal-Weight
PT $278

UBS

2026-06-26 · main

Buy → Buy
PT $352

Recent dividends

2026-10-16: $0.480 · 2026-07-17: $0.480 · 2026-04-15: $0.480 · 2026-01-16: $0.480 · 2025-10-17: $0.440 · 2025-07-11: $0.440 · 2025-04-11: $0.440 · 2025-01-24: $0.440

Insider trades

Polk Dennis